| Somatostatin | IC50 | 0.2 [1], 4.2 [2], 10.0 [3] |
| Somatostatin | Ki | 0.12 [1], 0.14 [2], 0.44 [3], 2.0 [4], 120.0 [5] |
| (4R,7S,10R,13S,16R,19S,22R,25S,28R,31S,34R,37S)-37-[[2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-carboxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid | IC50 | 2.4 [1] |
| (4R,7S,10R,13S,16R,19S,22R,25S,28R,31S,34R,37S)-37-[[2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-carboxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid | Ki | 0.4 [1] |
| (4R,7S,10S,13S,16R,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,19,22-tribenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid | IC50 | 46.0 [1] |
| (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2S,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | IC50 | 0.77 [1], 21.8 [2] |
| (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2S,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | Ki | 5.01 [1], 6.8 [2], 11.53 [3] |
| (4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-37-[[2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-carboxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1S)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-2-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid | IC50 | 2.4 [1], 2.5 [2], 2.9 [3], 3.9 [4] |
| CID 5311374 | IC50 | 10000.0 [1] |
| (4R,7S,10S,13S,16S,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,19,22-tribenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid | IC50 | 14.0 [1], 16.0 [2] |
| H-DPhe-c[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-NH2 | IC50 | 2.7 [1], 5.1 [2] |
| 2-(1-(4-Amino-3,5-diethoxybenzyl)piperidin-4-ylamino)benzo[d]oxazole-5-sulfonamide | Ki | 13.0 [1] |
| N-(1-(3-Ethoxy-4-methoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amine | IC50 | 740.0 [1] |
| N-(1-(3-Ethoxy-4-methoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amine | Ki | 121.0 [1] |
| N-[1-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]-5-methylpyridine-3-carboxamide | IC50 | 1.3 [1], 3.1 [2] |
| N-[1-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]-5-methylpyridine-3-carboxamide | Ki | 4.4 [1] |
| 4-[8-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 0.77 [1], 0.8 [2], 1.5 [3] |
| 4-[8-[(4,4-Dimethyl-2,3-dihydrochromen-6-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 1.1 [1], 1.5 [2], 1.54 [3] |
| Astemizole | Ki | 4070.0 [1] |
| Seglitide | IC50 | 81.0 [1] |
| Seglitide | Ki | 12.59 [1] |
| Cyclo(Pro-Phe-D-Trp-Lys-Thr-Phe) | Ki | 25.0 [1], 39.81 [2] |
| 8-D-Tryptophan-somatostatin | IC50 | 3.1 [1] |
| 8-D-Tryptophan-somatostatin | Ki | 0.46 [1] |
| (2S,3R)-2-[[(2S)-2-[(3S,6S,9S,12S,15S)-6-(4-Aminobutyl)-15-benzyl-12-[(4-hydroxyphenyl)methyl]-9-(1H-indol-3-ylmethyl)-2,5,8,11,14,20-hexaoxo-3-propan-2-yl-1,4,7,10,13,16,19-heptazacyclotricos-1-yl]-3-phenylpropanoyl]amino]-3-hydroxybutanamide | IC50 | 67.0 [1] |
| (2R,5R)-5-(4-Aminobutyl)-2-(1H-indol-3-ylmethyl)-7-(naphthalen-1-ylmethyl)-1,4,7-thiadiazonane-3,6-dione | IC50 | 87.0 [1] |
| (4R,7S,10S,13R,16S,19S)-10-(4-Aminobutyl)-19-[[(2S)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | Ki | 48.0 [1], 70.7 [2] |
| (4R,7S,10S,13S,16S,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,22-dibenzyl-10-[(1R)-1-hydroxyethyl]-19-[(4-hydroxyphenyl)methyl]-16-[(1S)-1-naphthalen-2-ylethyl]-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid | IC50 | 147.0 [1], 360.0 [2] |
| (4R,7S,10S,13S,16R,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,22-dibenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid | IC50 | 199.0 [1] |
| (4R,7S,10S,13S,16R,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,22-dibenzyl-10-[(1R)-1-hydroxyethyl]-19-[(4-hydroxyphenyl)methyl]-16-[(1S)-1-naphthalen-2-ylethyl]-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid | IC50 | 18.0 [1], 668.0 [2] |
| 2-(1-(3-Ethoxy-4-methoxybenzyl)piperidin-4-ylamino)benzo[d]oxazole-5-sulfonamide | Ki | 185.0 [1], 529.0 [2] |
| N-(1-(4-Chloro-3-ethoxybenzyl)piperidin-4-yl)-5-methylnicotinamide | Ki | 15.0 [1], 20.0 [2] |
| 4-((4-(Benzo[d]oxazol-2-ylamino)piperidin-1-yl)methyl)-2-ethoxyphenol | Ki | 66.0 [1] |
| N-(1-(3-(Cyclopentyloxy)-4-methoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amine | Ki | 83.0 [1] |
| Benzooxazol-2-yl-[1-(3-isobutoxy-4-methoxy-benzyl)-piperidin-4-yl]-amine | Ki | 23.0 [1] |
| N-(1-(4-Methoxy-3-propoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amine | Ki | 293.0 [1] |
| N-(1-(3-Ethoxy-4-fluorobenzyl)piperidin-4-yl)benzo[d]oxazol-2-amine | Ki | 194.0 [1] |
| N-(1-(4-Chloro-3-ethoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amine | Ki | 113.0 [1] |
| N-(1-(3-Ethoxy-4-methylbenzyl)piperidin-4-yl)benzo[d]oxazol-2-amine | Ki | 37.0 [1] |
| Des-AA1,2,5-[IAmp9,Tyr11]-SRIF | IC50 | 1000.0 [1] |
| (3R,6S,9R,12S,15R,18S)-9-(4-Aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-18-[[(2R)-2-amino-3-phenylpropanoyl]amino]-15-benzyl-6-[(1R)-1-hydroxyethyl]-12-(1H-indol-3-ylmethyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacyclononadecane-3-carboxamide | IC50 | 4.92 [1] |
| (2S,3R)-2-[[(3R,6S,9R,12S,15R,18S)-9-(4-Aminobutyl)-18-[[(2R)-2-amino-3-phenylpropanoyl]amino]-15-benzyl-6-[(1R)-1-hydroxyethyl]-12-(1H-indol-3-ylmethyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacyclononadecane-3-carbonyl]amino]-3-hydroxybutanoic acid | IC50 | 4.17 [1] |
| (4S,7R,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxylic acid | IC50 | 10.95 [1] |
| (4R,7S,10R,13S,16R,19S,22S,25S,28R,31R,34S)-31-(4-Aminobutyl)-34-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-19-[[4-[(propan-2-ylamino)methyl]phenyl]methyl]-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacontane-4-carboxylic acid | IC50 | 1000.0 [1] |
| SSTR5 antagonist 1 | IC50 | 9.6 [1] |
| (4R,7S,10S,13S,16S,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,22-dibenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acid | IC50 | 633.0 [1] |
| 4-[2-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-5-oxa-2,6-diazaspiro[3.4]oct-6-en-7-yl]cyclohexane-1-carboxylic acid | IC50 | 30.0 [1], 130.0 [2] |
| 4-[8-[[2-(2,4-Dichlorophenyl)-4-methyl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 2.4 [1], 3.2 [2] |
| 4-[8-[[3,5-Dichloro-4-(trifluoromethoxy)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 66.0 [1], 95.0 [2] |
| 5-[(1R,3R)-1-(1-Ethylpyrazol-4-yl)-3-[5-(5-fluoropyridin-2-yl)-1H-imidazol-2-yl]-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]-3-methyl-1,3,4-oxadiazol-2-one | IC50 | 1530.0 [1], 9240.0 [2] |
| SSTR5 antagonist 2 (TFA) | IC50 | 1.1 [1], 1.2 [2] |
| 9-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-3-pyridin-3-ylsulfonyl-3,9-diazaspiro[5.5]undecane | IC50 | 13.0 [1], 26.0 [2] |
| 4-[8-[(7-Methyl-1-propan-2-ylindol-3-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acid | IC50 | 28.0 [1], 33.0 [2] |
| 4-[8-[[4-(4-Fluorophenyl)-1-propan-2-ylindazol-3-yl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 222.0 [1], 276.0 [2] |
| 4-[8-[[2-(1-Methylpyrazol-4-yl)-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 1.0 [1], 5.5 [2] |
| 4-[8-[(4-Cyclopropyl-1-propan-2-ylindol-3-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acid | IC50 | 0.7 [1], 0.8 [2] |
| 4-Chloro-2-[1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]oxypyrimidine | IC50 | 21.0 [1], 73.0 [2] |
| 4-[1-(Benzenesulfonyl)piperidin-4-yl]-1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidine | IC50 | 0.7 [1], 8.6 [2] |
| 4-[8-[[4-Methyl-5-(trifluoromethyl)-2-(2,3,4-trifluorophenyl)phenyl]methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acid | IC50 | 4.9 [1], 20.0 [2] |
| 8-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-3-[(4-fluorophenyl)methyl]-1-oxa-8-azaspiro[4.5]decan-2-one | IC50 | 1.6 [1], 67.0 [2] |
| 1-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-4-[5-(4-fluorophenyl)-1H-imidazol-2-yl]piperidine | IC50 | 7.6 [1], 247.0 [2] |
| 4-[8-[[4-Chloro-2-cyclopropyl-5-(trifluoromethyl)phenyl]methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acid | IC50 | 19.0 [1], 37.0 [2] |
| 4-[8-[(8-Chloro-4,4-dimethyl-2,3-dihydrochromen-6-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acid | IC50 | 24.0 [1], 30.0 [2] |
| 4-[8-[(4,4-Dimethyl-2,3-dihydrochromen-6-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acid | IC50 | 109.0 [1], 161.0 [2] |
| 8-[[1-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]methoxy]quinoline | IC50 | 2.9 [1], 67.8 [2] |
| 4-[8-[[4-(4-Fluorophenyl)-3,5-dimethylphenyl]methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acid | IC50 | 17.0 [1], 36.0 [2] |
| 2-(1-(4-Chloro-3-ethoxybenzyl)piperidin-4-ylamino)benzo[d]oxazole-6-carboxylic acid | IC50 | 98.0 [1] |
| 2-(1-(4-Chloro-3-ethoxybenzyl)piperidin-4-ylamino)benzo[d]oxazole-6-carboxylic acid | Ki | 23.0 [1] |
| 2-(1-(3,5-Diethoxy-4-fluorobenzyl)piperidin-4-ylamino)benzo[d]oxazole-6-carboxylic acid | IC50 | 72.0 [1] |
| 2-(1-(3,5-Diethoxy-4-fluorobenzyl)piperidin-4-ylamino)benzo[d]oxazole-6-carboxylic acid | Ki | 18.0 [1] |
| (2S)-6-Amino-N-benzyl-2-[(4R)-3-oxo-4-[(2-phenylacetyl)amino]-1,4,5,10-tetrahydroazepino[3,4-b]indol-2-yl]hexanamide | IC50 | 1.2 [1] |
| 8-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione | IC50 | 83.0 [1], 110.0 [2] |
| (4R,7S,10S,13R,16S,19S)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | IC50 | 218.0 [1] |
| (4R,7S,10S,13R,16S,19S)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | Ki | 48.0 [1] |
| (4R,7S,10S,13R,16S,19S)-19-[[(2R)-2-Amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-10-[4-(methylamino)butyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | IC50 | 53.0 [1] |
| (4R,7S,10S,13R,16S,19S)-19-[[(2R)-2-Amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-10-[4-(methylamino)butyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | Ki | 50.0 [1] |
| SSTR5 antagonist 2 | IC50 | 1.1 [1], 1.2 [2] |
| 5-[[(2R,3R,4R,5S)-1-[2-(1H-Indol-3-yl)ethyl]-3,4,5-tris(phenylmethoxy)piperidin-2-yl]methoxy]pentan-1-amine | Ki | 5000.0 [1] |
| 4-[8-[(4,4-Dimethyl-2,3-dihydrothiochromen-6-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 0.6 [1], 1.5 [2] |
| 4-[8-[[3-Cyclopropyl-4-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 1.2 [1], 1.8 [2] |
| 4-[8-[(4-Cyclopropyl-1-propan-2-ylindol-3-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 0.1 [1], 0.3 [2] |
| 4-[8-[(2,2-Dimethyl-3,4-dihydrochromen-8-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 7.9 [1], 8.4 [2] |
| 4-[8-[[4-Methyl-2-pyridin-4-yl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 0.8 [1], 2.9 [2] |
| 2-[[(3As,6aR)-1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-4-yl]amino]-1,3-benzoxazole-6-carboxylic acid | IC50 | 2.5 [1], 4.5 [2] |
| 4-[8-[[2-Cyclopropyl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 2.1 [1], 2.4 [2] |
| 4-[8-[(4,4-Dimethyl-1,1-dioxo-2,3-dihydrothiochromen-6-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 30.0 [1], 31.0 [2] |
| 4-[8-[[4-Cyclopropyl-3-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 3.2 [1], 4.1 [2] |
| 4-[8-[(5-Cyclopropyl-2-methoxypyridin-3-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 5.7 [1], 8.2 [2] |
| 4-[8-[[4-Chloro-2-cyclopropyl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 0.4 [1], 0.7 [2] |
| 4-[8-[[4-(4-Fluorophenyl)-1-propan-2-ylpyrrolo[2,3-b]pyridin-3-yl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 0.4 [1] |
| 4-[2-Oxo-8-[[1-propan-2-yl-4-(2,3,4-trifluorophenyl)indol-3-yl]methyl]-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 0.2 [1], 0.5 [2] |
| 4-[8-[[4-Methyl-5-(trifluoromethyl)-2-(2,3,4-trifluorophenyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 1.2 [1], 3.2 [2] |
| 4-[8-[[3-Chloro-5-cyclopropyl-4-(2,4-difluorophenyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid | IC50 | 0.2 [1], 0.4 [2] |
| Lanreotide | Ki | 3.98 [1] |
| Pasireotide | Ki | 0.13 [1] |
| Edotreotide | IC50 | 393.0 [1] |
| Vapreotide | Ki | 5.01 [1] |
| (4R,7S,10S,13S,16S,19S,22R,25S,28S,31S,34R)-34-Amino-31-(4-aminobutyl)-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-19-[[4-[(propan-2-ylamino)methyl]phenyl]methyl]-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacontane-4-carboxylic acid | IC50 | 1000.0 [1] |
| CID 5311375 | IC50 | 0.4 [1] |
| [(2S)-2-Aminopropyl] (2R)-6-amino-2-[[2-(2-naphthalen-2-yl-1H-benzo[g]indol-3-yl)acetyl]amino]hexanoate | IC50 | 0.4 [1] |